ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,442Medicare Part D Prescriptions Filled, Including Refills

Rank: 530 out of 2061

$540K Total Retail Price of All Prescriptions

Rank: 601 out of 2061

385 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,609 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 441 427 1 1
LEVOTHYROXINE SODIUM 323 293 2 3
OMEPRAZOLE 307 284 3 5
CARVEDILOL 301 294 4 22
WARFARIN SODIUM 285 256 5 11
AMLODIPINE BESYLATE 276 259 6 4
FUROSEMIDE 264 248 7 6
LISINOPRIL 236 195 8 2
POTASSIUM CHLORIDE 215 202 9 16
LOSARTAN POTASSIUM 212 207 10 17
HYDROCHLOROTHIAZIDE 181 169 11 12
HYDROCODONE-ACETAMINOPHEN 164 148 S3 12 10
METOPROLOL TARTRATE 147 133 13 7
ALLOPURINOL 145 123 14 28
ATORVASTATIN CALCIUM 123 107 15 8
METFORMIN HCL 122 100 16 9
GABAPENTIN 113 110 17 15
SERTRALINE HCL 100 90 18 21
GLIMEPIRIDE 100 100 18 33
DONEPEZIL HCL 100 100 18 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 86 21 27
TRAMADOL HCL 85 85 22 18
NEXIUM 82 81 23 26
VERAPAMIL ER 81 81 24 100
LACTULOSE 77 72 25 131
AZITHROMYCIN 73 67 26 34
ISOSORBIDE MONONITRATE ER 72 69 27 42
CLOPIDOGREL 63 55 28 29
OXYCODONE-ACETAMINOPHEN 61 54 S2 29 36
PROAIR HFA 61 61 29 40
TAMSULOSIN HCL 60 58 31 30
MIRTAZAPINE 59 59 32 46
CLONIDINE HCL 59 47 32 52
PRAMIPEXOLE DIHYDROCHLORIDE 58 48 34 249
CITALOPRAM HBR 58 53 34 20
TRIAMTERENE-HCTZ 57 57 36 38
PANTOPRAZOLE SODIUM 56 54 37 45
TRAZODONE HCL 56 46 37 39
ALENDRONATE SODIUM 54 52 39 25
PLAVIX 54 45 39 49
SINGULAIR 53 39 41 88
PREDNISONE 53 52 41 32
CRESTOR 53 47 41 31
FINASTERIDE 52 52 44 86
POLYETHYLENE GLYCOL 3350 51 51 45 64
NAMENDA 51 51 45 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.